Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 70.96 per share at the end of the most recent trading day (a 0.72% change compared to the prior day closing price) with a volume of 510.12K shares and market capitalization of 6.52B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.

The one-year performance of Acadia Healthcare Company Inc. stock is 8.78%, while year-to-date (YTD) performance is -13.8%. ACHC stock has a five-year performance of 75.04%. Its 52-week range is between 63.2 and 89.85, which gives ACHC stock a 52-week price range ratio of 30.60%

Acadia Healthcare Company Inc. currently has a PE ratio of 26.80, a price-to-book (PB) ratio of 2.75, a price-to-sale (PS) ratio of 3.83, a price to cashflow ratio of 20.80, a PEG ratio of 2.32, a ROA of 6.39%, a ROC of 8.04% and a ROE of 11.75%. The company’s profit margin is 11.21%, its EBITDA margin is 22.30%, and its revenue ttm is $1.94 Billion , which makes it $21.27 revenue per share.

Of the last four earnings reports from Acadia Healthcare Company Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.71 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 02nd May 2023.

The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2.08), with a target price of $90.54, which is +27.49% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Acadia Healthcare Company Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.02, ATR14 : 2.05, CCI20 : -40.12, Chaikin Money Flow : -0.09, MACD : -2.80, Money Flow Index : 47.97, ROC : -4.66, RSI : 39.31, STOCH (14,3) : 50.09, STOCH RSI : 1.00, UO : 59.27, Williams %R : -49.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were: Christopher L. Howard (Option Excercise at a value of $311 453), Christopher L. Howard (Sold 20 657 shares of value $1 685 706 ), David Duckworth (Sold 26 921 shares of value $2 170 677 ), John S. Hollinsworth (Sold 10 780 shares of value $869 730 ), William F. Grieco (Sold 5 000 shares of value $412 700 )